Search and destroy policy for methicillin-resistant Staphylococcus aureus: Cost-benefit analysis

Journal of Advanced Nursing

Volumn 65, Issue 9, 2009, Pages 1853-1859

  Simoens, Steven ^a   Ophals, Erik ^a   Schuermans, Annette ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Cost benefit analysis; Methicillin resistant Staphylococcus aureus; Nursing; Search and destroy policy

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; CROSS INFECTION; ECONOMICS; HOSPITALIZATION; HUMAN; INFECTION CONTROL; ISOLATION AND PURIFICATION; MASS SCREENING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHODOLOGY; NURSING; ORGANIZATION AND MANAGEMENT; PROSPECTIVE STUDY; STAPHYLOCOCCUS INFECTION;

COST-BENEFIT ANALYSIS; CROSS INFECTION; HOSPITALIZATION; HUMANS; INFECTION CONTROL; MASS SCREENING; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS;

EID: 68849095190     PISSN: 03092402     EISSN: 13652648     Source Type: Journal    
DOI: 10.1111/j.1365-2648.2009.05050.x     Document Type: Article

References (14)

1. Baird V. Hawley R. (2000) Methicillin-resistant Staphylococcus aureus (MRSA): is there a need to change clinical practice? Intensive and Critical Care Nursing 16, 357 366.
2. Coia J., Duckworth G., Edwards D., Farrington M., Fry C., Humphreys H., Mallaghan C. Tucker D., for the Joint Working Party of the British Society of Antimicrobial Chemotherapy, the Hospital Infection Society, and the Infection Control Nurses Association 2006) Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. Journal of Hospital Infection 63S, S1 S44.
3. Cooper B., Stone S., Kibbler C., Cookson B., Roberts J., Medley G., Duckworth G., Lai R. Ebrahim S. (2003) Systematic review of isolation policies in the hospital management of methicillin-resistant staphylococcus aureus: a review of the literature with epidemiological and economic modeling. Health Technology Assessment 7, 39.
4. Cosgrove S., Sakoulas G., Perencevich E., Schwaber M., Karchmer A. Carmeli Y. (2003) Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta- analysis. Clinical Infectious Diseases 36, 53 59. (Pubitemid 36099097)
5. Cosgrove S., Qi Y. Kaye K.S. (2005) The impact of methicillin resistance in staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infection Control and Hospital Epidemiology 26, 166 174.
6. Henderson D. (2006) Managing methicillin-resistant staphylococci: a paradigm for preventing nosocomial transmission of resistant organisms. The American Journal of Medicine 119 (Suppl. 6A S45 S52. (Pubitemid 43776139)
7. Jans B. Streulens M. (2005) Surveillance van MRSA in de Belgische ziekenhuizen: eerste semester 2005 (Surveillance of MRSA in Belgian Hospitals: First Semester of 2005). Retrieved from http://www.nsih.be/download/mrsa-Rapnl51 on 12 April 2007.
8. Klevens R.M., Morrison M.A. Nadle J., on behalf of the Active Bacterial Core surveillance (ABCs) MRSA Investigators 2007) Invasive methicillin-resistant Staphylococcus aureus infections in the United States. Journal of the American Medical Association 298, 1763 1771.
9. Lines L. (2006) Study of senior staff nurses' perceptions about MRSA. Nursing Times 102, 32 35.
10. Nettleman M., Trilla A., Fredrickson M. Pfaller M. (1991) Assigning responsibility: using feedback to achieve sustained control of methicillin-resistant staphylococcus aureus. American Journal of Medicine 91 (Suppl. 3B 228 232.
11. Shorr A. (2007) Epidemiology and economic impact of meticillin-resistant Staphylococcus aureus. Review and analysis of the literature. Pharmacoeconomics 25, 751 768.
12. Spicer W. (1984) Three strategies in the control of staphylococci, including methicillin-resistant staphylococcus aureus. Journal of Hospital Infection 5 (Suppl. A 45 49.
13. Van den berghe G., Wouters P., Kesteloot K. Hilleman E. (2006) Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients. Critical Care Medicine 34, 612 616.
14. Vriens M., Blok H., Fluit A., Troelstra A., van der Werken C. Verhoef J. (2002) Costs associated with a strict policy to eradicate methicillin-resistant staphylococcus aureus in a Dutch university medical center: a 10-year survey. European Journal of Clinical Microbiology and Infectious Diseases 21, 782 786.